title: Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
authors.affiliation: Cancer and Blood Specialists of Nevada, Henderson, NV 89052, USA. rgollard@hotmail.com
authors.forename: Russell P
authors.initials: RP
authors.lastname: Gollard
authors.forename: Scott
authors.initials: S
authors.lastname: Selco
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001087:Arabinonucleosides / Q000008:administration & dosage / Q000009:adverse effects*; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011782:Quadriplegia / Q000139:chemically induced*; D013116:Spinal Cord / Q000473:pathology*; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology
chemical_list: D001087:Arabinonucleosides; C104457:nelarabine; D015122:Mercaptopurine; D008727:Methotrexate